The PPMD team is joined by leading Duchenne researchers to discuss exciting areas of research in development that hold promise for Duchenne, such as gene editing and non-viral delivery. Panelists: Kevin Flanigan, MD, Nationwide Children’s Hospital Melissa Spencer, PhD, UCLA 2020 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 4 years ago You may also like 7:11 Epirium Bio 4 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 18:36 Sarepta Therapeutics (RNA Targeted Therapies) 4 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:46 NS Pharma 4 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:20 PTC Therapeutics (Ataluren) 4 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 15:10 Daiichi-Sankyo 4 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 20:43 ReveraGen BioPharma 4 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 12:20 Catabasis 4 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 11:23 Antisense Therapeutics 4 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation «1…1920212223…25»Page 21 of 25